Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB, Canada.
Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Cryobiology. 2024 Sep;116:104883. doi: 10.1016/j.cryobiol.2024.104883. Epub 2024 Mar 6.
Post-thaw cell viability assessment is very important in cryopreservation because it is the main assessment method used to optimize cryopreservation protocols for each cell type; hence, having standardized accurate, quick, and reliable assays for post-thaw cell viability measurements is of utmost importance. The trypan blue exclusion assay and nucleic-acid-binding fluorescence-based assays are two different methods for cell viability assessment. Both assays identify cells with damaged membranes by whether they let a compound enter the cell. In this study, these two assays are compared in the context of cryopreservation and the impacts of important cryopreservation parameters on the differences in measurements are investigated. H9c2 myoblasts were cryopreserved with different freezing protocols. Cell membrane integrities were measured immediately after thaw as well as after cryoprotectant removal by a hemocytometer-based trypan blue dye exclusion assay and a dual fluorometric SYTO 13/GelRed assay; and the results were compared. This study quantifies how (i) the absence or presence of different cryoprotectants, (ii) different cell-cryoprotectant incubation conditions, and (iii) the presence or removal of cryoprotectants after thaw affect the differences between these two viability assays.
解冻后细胞活力评估在细胞冻存中非常重要,因为它是优化每种细胞类型冻存方案的主要评估方法; 因此,拥有标准化的、准确的、快速的和可靠的用于解冻后细胞活力测量的检测方法至关重要。台盼蓝排斥试验和基于核酸结合荧光的检测方法是两种不同的细胞活力评估方法。这两种检测方法都通过是否允许化合物进入细胞来识别细胞膜受损的细胞。在本研究中,这两种检测方法在细胞冻存方面进行了比较,并研究了重要的冻存参数对测量差异的影响。使用不同的冷冻方案对 H9c2 成肌细胞进行冻存。在解冻后以及通过血球计数器台盼蓝染料排斥试验和双荧光 SYTO 13/GelRed 试验去除细胞保护剂后,立即测量细胞膜完整性,并对结果进行比较。本研究量化了以下因素如何影响这两种活力检测方法之间的差异:(i) 不同细胞保护剂的存在或不存在,(ii) 不同的细胞-细胞保护剂孵育条件,以及 (iii) 解冻后细胞保护剂的存在或去除。